- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01958450
Comparison of the Efficacy of Fractional Er:YAG Laser for Acne Scar
October 9, 2013 updated by: Dae Hun Suh, Seoul National University Hospital
Comparitive Study of Efficacy and Safety Between Fractional Er:YAG Laser and Bipolar Radiofrequency Treatment for Acne Scar
Compare the efficacy of frational Er:YAG laser and that of bipolar frequency with diode laser treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In acne scar treatment, ablational laser would be superior to nonablative laser treatment.
Frational Er:YAG laser treatment is a effective treatment plan for acne scar without severe adverse effects.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Department of Dermatology, Seoul National University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- moderate acne scar
Exclusion Criteria:
- taking steroids, nonsteroidal antiinflammatory drug, and isotretinoin
- anyone who received acne scar procedures within 6 months
- underlying diabetes mellitus, keloid, or malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Er:YAG laser
acne scar treatment using Er:YAG laser
|
acne scar treatment using Er:YAG laser
|
|
Active Comparator: Bipolar radiofrequency with diode laser
|
acne scar treatment with bipolar radiofrequency combined with diode laser
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global asessment of acne scar
Time Frame: 12 weeks
|
5 point grading of acne scar
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ECCA
Time Frame: 12 weeks
|
quantative assessement of acne scar
|
12 weeks
|
|
adverse effect assessment
Time Frame: 12 weeks
|
adverse effect assessment
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
October 6, 2013
First Submitted That Met QC Criteria
October 6, 2013
First Posted (Estimate)
October 9, 2013
Study Record Updates
Last Update Posted (Estimate)
October 11, 2013
Last Update Submitted That Met QC Criteria
October 9, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-1061
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.